CD8A and melanoma: Moreover, enhanced cytotoxic CD8+ T cell frequencies within the tumor microenvironment (TME) are correlated with favorable outcomes in breast (4, 5), colorectal (6), melanoma (7), ovarian (8), and pancreatic cancers (9).